Philips Introduces Newly Enhanced Cardiac Ultrasound System

By Royal Philips Electronics, PRNE
Sunday, August 29, 2010

iE33 xMATRIX system offers expanded clinical applications in cardiac ultrasound imaging

STOCKHOLM, August 30, 2010 - Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced the
enhanced iE33 xMATRIX cardiac ultrasound system featuring a new ergonomic
solution for more efficient adult echocardiograms, the X5-1 transducer. With
this enhanced technology, Philips continues its tradition of simplified,
patient-focused healthcare solutions by providing a more complete imaging
solution. The system enables expanded cardiac-related diagnostic capabilities
related to ischemic disease detection, structural heart disease assessment,
as well as systolic and diastolic heart failure and arrhythmia. Aimed at
supporting workflow improvements as well as providing clinical benefits, the
iE33 xMATRIX cardiac ultrasound system will be a highlighted display at the
European Society of Cardiology Congress (ESC) in Stockholm, August 28 through
September 1
.

"The new iE33 xMATRIX ultrasound system represents a significant
breakthrough in ultrasound; technology that gives clinicians new diagnostic
tools and helps them examine patients more quickly," said Andrew Hatt, vice
president and interim general manager, Ultrasound, for Philips Healthcare.
"In addition, clinicians who have experienced scanning fatigue will
appreciate that the X5-1 transducer combines the ergonomics of 2D transducers
with the three-dimensional technology they need, to make the most informed
patient care decisions possible."

Continuing the tradition of expanding advanced capabilities throughout
the Philips cardiac ultrasound portfolio, new features of the iE33 xMATRIX
ultrasound system include outstanding 2D and 3D image quality utilizing a
single transducer, near instantaneous acquisition of 3D volumes, new 3D
workflow tools and visualized color Doppler flow pattern during 3D exams.
With the X5-1 and iRotate, a clinician can more easily obtain challenging 2D
views, such as apical two-chamber. Rather than manually rotating the
transducer and searching for a window that isn't obscured by ribs, rotation
is achieved electronically to maintain the best acoustical window. When used
in stress echo, iRotate allows clinicians to complete an entire stress echo
protocol from the standard windows following peak exertion without rotating
the X5-1 transducer.

The iE33 xMATRIX ultrasound system also offers a 3D stress echo solution
that can be incorporated with conventional 2D stress echo. After acquiring a
volume, clinicians can then use the system's advanced iSlice software to
obtain short axis views of the heart's apex. This constitutes additional
clinical information that is not routinely obtained by ultrasound.

More information can be found at: bit.ly/PhilipsatESC2010 .

You can also visit us at ESC 2010 in Exhibition Area Zone C, booth number
C50:30 at the Stockholmsmassan in Stockholm.

About Royal Philips Electronics

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a
diversified health and well-being company, focused on improving people's
lives through timely innovations. As a world leader in healthcare, lifestyle
and lighting, Philips integrates technologies and design into people-centric
solutions, based on fundamental customer insights and the brand promise of
"sense and simplicity". Headquartered in the Netherlands, Philips employs
more than 116,000 employees in more than 60 countries worldwide. With sales
of EUR 23 billion in 2009, the company is a market leader in cardiac care,
acute care and home healthcare, energy efficient lighting solutions and new
lighting applications, as well as lifestyle products for personal well-being
and pleasure with strong leadership positions in flat TV, male shaving and
grooming, portable entertainment and oral healthcare. News from Philips is
located at www.philips.com/newscenter.

Steve Kelly of Philips Healthcare, +1-425-487-7479, or steve.kelly at philips.com, Sabine van Deursen of Philips Healthcare Communications, +31(0)40-2785-093, or sabine.van.deursen at philips.com

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :